首页 > 最新文献

Saudi Medical Journal最新文献

英文 中文
Biological studies of the activity of Manuka honey against Carbapenem-resistant Enterobacterales (CRE) bacteria. 麦卢卡蜂蜜对耐碳青霉烯类肠杆菌(CRE)活性的生物学研究。
IF 1.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-01 DOI: 10.15537/smj.2024.45.9.20240153
Mamdouh A Bukhari, Razaz A Qamash, Rasha A Bulkhi, Jehad A Bifari, Omar S Bakhsh, Khalid O Hawsawi, Ehab Y Matuure, Kamil A Sulaimani, Ashwaq T Hakim, Maher S Mujahid

Objectives: To evaluate the potency of Manuka honey UMF +15 against Carbapenem-resistant Enterobacterales (CRE). Bacterial resistance is a worldwide problem that is increasing year by year, especially Carbapenem resistance. Alternatives to antibiotics are needed to both reduce costs, and to reduce the spread of antibiotic resistance, with the ultimate goal of saving lives.

Methods: The efficacy of Manuka honey UMF +15 was tested by 2 methods; Well diffusion assay and minimum bactericidal concentration (MBC) against twenty Carbapenem-resistant isolates which collected from Makkah city hospitals during three months of study from 1st of September 2023 up to 1st of December 2023.

Results: The growth of all isolates of Carbapenem-resistant Enterobacterales (CRE) was severely inhibited by low concentrations of Manuka honey, affecting 25% of isolates at 15% and 75% of isolates at 18% of Manuka honey. In addition, using the honey at different concentrations in a well diffusion assay resulted, as expected, in a variable zone diameter, ranging from large zones(14mm) to small zones (2 mm) according to the concentration of the honey.

Conclusion: This study shows the remarkable antibacterial activity of Manuka honey and suggests that this natural remedy might be used in the future as an alternative treatment option against Carbapenem-resistant Enterobacterales (CRE); however, further clinical trials should be performed to corroborate our initial findings.

目的评估麦卢卡蜂蜜 UMF +15 对耐碳青霉烯类肠杆菌(CRE)的药效。细菌耐药性是一个全球性问题,且逐年增加,尤其是对碳青霉烯类的耐药性。我们需要抗生素的替代品来降低成本,减少抗生素耐药性的传播,最终达到挽救生命的目的:方法:在 2023 年 9 月 1 日至 2023 年 12 月 1 日的三个月研究期间,采用两种方法测试了麦卢卡蜂蜜 UMF +15 对从麦加市医院采集的 20 个耐碳青霉烯类细菌分离物的疗效:井扩散试验和最低杀菌浓度(MBC):低浓度麦卢卡蜂蜜严重抑制了所有耐碳青霉烯类肠杆菌(CRE)分离物的生长,浓度为 15% 的麦卢卡蜂蜜对 25% 的分离物有影响,浓度为 18% 的麦卢卡蜂蜜对 75% 的分离物有影响。此外,在井扩散试验中使用不同浓度的麦卢卡蜂蜜也会产生不同的区域直径,从大区域(14 毫米)到小区域(2 毫米)不等:这项研究表明麦卢卡蜂蜜具有显著的抗菌活性,并表明这种天然疗法在未来可用作抗耐碳青霉烯类肠杆菌(CRE)的替代疗法。
{"title":"Biological studies of the activity of Manuka honey against Carbapenem-resistant Enterobacterales (CRE) bacteria.","authors":"Mamdouh A Bukhari, Razaz A Qamash, Rasha A Bulkhi, Jehad A Bifari, Omar S Bakhsh, Khalid O Hawsawi, Ehab Y Matuure, Kamil A Sulaimani, Ashwaq T Hakim, Maher S Mujahid","doi":"10.15537/smj.2024.45.9.20240153","DOIUrl":"10.15537/smj.2024.45.9.20240153","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the potency of Manuka honey UMF +15 against Carbapenem-resistant Enterobacterales (CRE). Bacterial resistance is a worldwide problem that is increasing year by year, especially Carbapenem resistance. Alternatives to antibiotics are needed to both reduce costs, and to reduce the spread of antibiotic resistance, with the ultimate goal of saving lives.</p><p><strong>Methods: </strong>The efficacy of Manuka honey UMF +15 was tested by 2 methods; Well diffusion assay and minimum bactericidal concentration (MBC) against twenty Carbapenem-resistant isolates which collected from Makkah city hospitals during three months of study from 1st of September 2023 up to 1st of December 2023.</p><p><strong>Results: </strong>The growth of all isolates of Carbapenem-resistant Enterobacterales (CRE) was severely inhibited by low concentrations of Manuka honey, affecting 25% of isolates at 15% and 75% of isolates at 18% of Manuka honey. In addition, using the honey at different concentrations in a well diffusion assay resulted, as expected, in a variable zone diameter, ranging from large zones(14mm) to small zones (2 mm) according to the concentration of the honey.</p><p><strong>Conclusion: </strong>This study shows the remarkable antibacterial activity of Manuka honey and suggests that this natural remedy might be used in the future as an alternative treatment option against Carbapenem-resistant Enterobacterales (CRE); however, further clinical trials should be performed to corroborate our initial findings.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11376693/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142111527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nearly 1.8 billion adults at risk of disease from not doing enough physical activity. 近 18 亿成年人因缺乏足够的体育锻炼而面临患病风险。
IF 1.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-01
{"title":"Nearly 1.8 billion adults at risk of disease from not doing enough physical activity.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288492/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141793370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is postoperative adjuvant radiotherapy necessary for patients with esophageal cancer after neoadjuvant chemoradiotherapy? An analysis based on the SEER database. 新辅助化放疗后的食管癌患者是否需要术后辅助放疗?基于 SEER 数据库的分析。
IF 1.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-01 DOI: 10.15537/smj.2024.45.9.20240045
Qiuying An, Yuhao Su, Yajing Wang, Chanjun Zhen, Wenwen Bai, Liyuan Fu, Yibing Liu, Ping Zhang, Zhiguo Zhou

Objectives: To evaluate the outcomes of adjuvant radiotherapy in patients with esophageal cancer (EC) who underwent esophagectomy following neoadjuvant chemoradiotherapy (NCRT).

Methods: The data of EC patients who received adjuvant therapy after NCRT between 2004 to 2019 was retrieved from the SEER database. The patients were split into the adjuvant radiotherapy with or without chemotherapy (RT±CT) and the adjuvant chemotherapy (CT) groups. The process of propensity score matching (PSM) was employed.

Results: Following PSM, 157 patients in total were recruited in each treatment group. There were no significant variations in either overall survival (OS) or cancer-specific survival (CSS) between the RT±CT and CT groups (median OS: 28 months versus. 51 months, p=0.063; median CSS: 31 months versus. 52 months, p=0.16). Within the CT group, patients with ypI/II or cI/II tumor stage, positive lymph node ratio (LNR) ≤0.1, and tumor size ≥50 mm (p<0.05) had higher OS compared to the RT±CT groups. Among patients with cT3-4 tumors in N-stage downstaging group, the OS and CSS were significantly greater for those underwent RT±CT as opposed to the CT group (5-year OS:56.6% versus 19.4%, p=0.042; 5-year CSS:67.9% versus. 19.4%, p=0.023). Multivariate Cox regression analysis identified the tumor histology grade as an independent prognostic factor of OS and CSS.

Conclusion: Radiotherapy-based adjuvant therapy does not significantly improve the prognosis of EC patients after NCRT, although it may provide a survival benefit for patients with cT3-4 tumors in N-stage downstaging.

目的评估新辅助化放疗(NCRT)后接受食管切除术的食管癌(EC)患者的辅助放疗效果:从SEER数据库中检索了2004年至2019年期间接受新辅助化放疗后辅助治疗的食管癌患者的数据。患者被分为辅助放疗加或不加化疗(RT±CT)组和辅助化疗(CT)组。结果:经过倾向得分匹配,各治疗组共招募了 157 名患者。RT±CT组和CT组的总生存期(OS)和癌症特异性生存期(CSS)均无明显差异(中位OS:28个月对CSS:1个月对1个月):28个月对51个月,P=0.063;中位CSS:31个月对:31个月对52个月,P=0.16)。在CT组中,ypI/II或cI/II肿瘤分期、阳性淋巴结比值(LNR)≤0.1、肿瘤大小≥50 mm的患者(P=0.042;5年CSS:67.9%对19.4%,P=0.023)。多变量考克斯回归分析发现,肿瘤组织学分级是OS和CSS的独立预后因素:结论:以放疗为基础的辅助治疗并不能明显改善NCRT后EC患者的预后,尽管它可以为N期降级的cT3-4肿瘤患者带来生存获益。
{"title":"Is postoperative adjuvant radiotherapy necessary for patients with esophageal cancer after neoadjuvant chemoradiotherapy? An analysis based on the SEER database.","authors":"Qiuying An, Yuhao Su, Yajing Wang, Chanjun Zhen, Wenwen Bai, Liyuan Fu, Yibing Liu, Ping Zhang, Zhiguo Zhou","doi":"10.15537/smj.2024.45.9.20240045","DOIUrl":"10.15537/smj.2024.45.9.20240045","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the outcomes of adjuvant radiotherapy in patients with esophageal cancer (EC) who underwent esophagectomy following neoadjuvant chemoradiotherapy (NCRT).</p><p><strong>Methods: </strong>The data of EC patients who received adjuvant therapy after NCRT between 2004 to 2019 was retrieved from the SEER database. The patients were split into the adjuvant radiotherapy with or without chemotherapy (RT±CT) and the adjuvant chemotherapy (CT) groups. The process of propensity score matching (PSM) was employed.</p><p><strong>Results: </strong>Following PSM, 157 patients in total were recruited in each treatment group. There were no significant variations in either overall survival (OS) or cancer-specific survival (CSS) between the RT±CT and CT groups (median OS: 28 months versus. 51 months, <i>p</i>=0.063; median CSS: 31 months versus. 52 months, <i>p</i>=0.16). Within the CT group, patients with ypI/II or cI/II tumor stage, positive lymph node ratio (LNR) ≤0.1, and tumor size ≥50 mm (<i>p</i><0.05) had higher OS compared to the RT±CT groups. Among patients with cT3-4 tumors in N-stage downstaging group, the OS and CSS were significantly greater for those underwent RT±CT as opposed to the CT group (5-year OS:56.6% versus 19.4%, <i>p</i>=0.042; 5-year CSS:67.9% versus. 19.4%, <i>p</i>=0.023). Multivariate Cox regression analysis identified the tumor histology grade as an independent prognostic factor of OS and CSS.</p><p><strong>Conclusion: </strong>Radiotherapy-based adjuvant therapy does not significantly improve the prognosis of EC patients after NCRT, although it may provide a survival benefit for patients with cT3-4 tumors in N-stage downstaging.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11376696/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142111534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Newborn hearing screening in Eastern Saudi Arabia: A tertiary hospital experience. 沙特阿拉伯东部的新生儿听力筛查:一家三级医院的经验。
IF 1.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-01 DOI: 10.15537/smj.2024.45.9.20240365
Amal A Al-Shaikh Sulaiman

Objectives: To analyze the performance of a leading institution in implementing newborn hearing screening and address two key areas: the knowledge gap in screening practice and the prevalence of permanent sensorineural hearing loss in Saudi Arabia.

Methods: We analyzed the prevalence of hearing impairment in all live births at King Fahad Hospital of the University, Al Khobar, Saudi Arabia, from September 2018 to June 2022. Automated auditory brainstem response was used for both initial screening and rescreening. Newborns who failed the rescreening underwent a diagnostic evaluation. We assessed the coverage of initial screening, the rate of lost follow-up, referrals for rescreening and diagnostic evaluation, and the prevalence of hearing impairment.

Results: A total of 5,986 newborns were born. Of these, 96.5% were screened. The passing rate for the initial screening and rescreening was 71.8%. However, 27.5% of newborns were lost to follow-up. Only 0.7% required referral for a diagnostic evaluation. The overall prevalence of hearing impairment was 2.6 per 1,000 newborns.

Conclusion: Early identification of hearing loss through newborn screening improves the lives of affected individuals. Our program currently meets the World Health Organization's 1-3-6 benchmark goals. However, the underestimation of permanent hearing loss due to the 30% lost-to-follow-up rate is a limitation. Emphasizing the importance of the screening program is crucial to raising awareness and improving the accuracy of prevalence rates.

目的分析一家领先机构在实施新生儿听力筛查方面的表现,并解决两个关键领域的问题:筛查实践中的知识差距和沙特阿拉伯永久性感音神经性听力损失的患病率:我们分析了 2018 年 9 月至 2022 年 6 月期间沙特阿拉伯 Al Khobar 法赫德国王大学医院所有活产婴儿的听力障碍患病率。初筛和复筛均使用了自动听性脑干反应。未能通过复筛的新生儿接受了诊断评估。我们评估了初筛的覆盖率、随访遗失率、复筛和诊断评估的转诊率以及听力障碍的患病率:共有 5986 名新生儿出生。结果:共有 5,986 名新生儿出生,其中 96.5%接受了筛查。初筛和复筛的通过率为 71.8%。不过,有 27.5% 的新生儿失去了随访机会。只有 0.7% 的新生儿需要转诊进行诊断评估。听力障碍的总体发病率为每千名新生儿 2.6 例:结论:通过新生儿筛查及早发现听力损失可改善受影响儿童的生活。我们的计划目前已达到世界卫生组织的 1-3-6 基准目标。然而,由于 30% 的失访率,对永久性听力损失的低估是一个局限。强调筛查计划的重要性对于提高认识和提高患病率的准确性至关重要。
{"title":"Newborn hearing screening in Eastern Saudi Arabia: A tertiary hospital experience.","authors":"Amal A Al-Shaikh Sulaiman","doi":"10.15537/smj.2024.45.9.20240365","DOIUrl":"10.15537/smj.2024.45.9.20240365","url":null,"abstract":"<p><strong>Objectives: </strong>To analyze the performance of a leading institution in implementing newborn hearing screening and address two key areas: the knowledge gap in screening practice and the prevalence of permanent sensorineural hearing loss in Saudi Arabia.</p><p><strong>Methods: </strong>We analyzed the prevalence of hearing impairment in all live births at King Fahad Hospital of the University, Al Khobar, Saudi Arabia, from September 2018 to June 2022. Automated auditory brainstem response was used for both initial screening and rescreening. Newborns who failed the rescreening underwent a diagnostic evaluation. We assessed the coverage of initial screening, the rate of lost follow-up, referrals for rescreening and diagnostic evaluation, and the prevalence of hearing impairment.</p><p><strong>Results: </strong>A total of 5,986 newborns were born. Of these, 96.5% were screened. The passing rate for the initial screening and rescreening was 71.8%. However, 27.5% of newborns were lost to follow-up. Only 0.7% required referral for a diagnostic evaluation. The overall prevalence of hearing impairment was 2.6 per 1,000 newborns.</p><p><strong>Conclusion: </strong>Early identification of hearing loss through newborn screening improves the lives of affected individuals. Our program currently meets the World Health Organization's 1-3-6 benchmark goals. However, the underestimation of permanent hearing loss due to the 30% lost-to-follow-up rate is a limitation. Emphasizing the importance of the screening program is crucial to raising awareness and improving the accuracy of prevalence rates.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11376704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142111537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Middle East Immunology Summit of the Gulf Cooperation Council Association of Immunology and Rheumatology (GCC AIR), 2023 Dubai, United Arab Emirate. Scientific abstracts and case reports. 海湾合作委员会免疫学和风湿病学协会中东免疫学峰会,2023 年,阿拉伯联合酋长国迪拜。科学摘要和病例报告。
IF 1.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-01
Ahmed S Zayat, Sadeya Naji, Omar Syed, Adeeba Al Herz, Ahmed Elasareeri, Mira Merashli, Mahdi Abusalameh, Waleed Hafiz, Elsadeg Sharif, Martin Lee, Fahdah Alokaily, Suad Hannawi
{"title":"Middle East Immunology Summit of the Gulf Cooperation Council Association of Immunology and Rheumatology (GCC AIR), 2023 Dubai, United Arab Emirate. Scientific abstracts and case reports.","authors":"Ahmed S Zayat, Sadeya Naji, Omar Syed, Adeeba Al Herz, Ahmed Elasareeri, Mira Merashli, Mahdi Abusalameh, Waleed Hafiz, Elsadeg Sharif, Martin Lee, Fahdah Alokaily, Suad Hannawi","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11376690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142111535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does air pollution affect lupus risk? 空气污染会影响狼疮风险吗?
IF 1.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-01
{"title":"Does air pollution affect lupus risk?","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288496/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141793292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of the prone position on mechanical power in elective surgical patients under general anesthesia: A prospective observational study. 俯卧位对全身麻醉下择期手术患者机械力的影响:前瞻性观察研究。
IF 1.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-01 DOI: 10.15537/smj.2024.45.8.20240242
Berrak S Aydın, Eren Açıkgöz

Objectives: To evaluate how the prone position influences mechanical power (MP) during elective surgical procedures.

Methods: In this prospective study carried out at Karadeniz Ereğli Government Hospital, Zonguldak, Turkey, from January 2024 to February 2024, 76 patients under general anesthesia were evaluated at different time points during the surgical procedure. Hemodynamic, laboratory, and mechanical ventilation data were also recorded.

Results: The MP increased in the prone position at the beginning of surgery. Transitioning to the supine position at the end of surgery led to a decrease in MP. At the end of surgery, the mean MP in supine and prone positions was found to be higher compared to those measured in the first hour of surgery. Mechanical power and body mass index (BMI) exhibited a significant positive correlation.

Conclusion: Position changes influence MP. Returning to the prone position increases MP. An increase in BMI is associated with an increase in MP.ANZCTR Reg. No.: ACTRN12623001281684.

目的:评估俯卧位如何影响择期手术过程中的机械力(MP):评估俯卧位如何影响择期手术过程中的机械力(MP):这项前瞻性研究于 2024 年 1 月至 2024 年 2 月在土耳其宗古尔达克的 Karadeniz Ereğli 政府医院进行,在手术过程中的不同时间点对 76 名全身麻醉患者进行了评估。同时还记录了血液动力学、实验室和机械通气数据:结果:手术开始时,俯卧位的血压升高。结果:手术开始时,俯卧位的 MP 值升高;手术结束时,转为仰卧位的 MP 值降低。手术结束时,发现仰卧位和俯卧位的平均 MP 值高于手术最初一小时的测量值。机械力与体重指数(BMI)呈显著正相关:结论:体位变化会影响肌力。结论:体位变化会影响肌力,恢复俯卧位会增加肌力。BMI 的增加与 MP 的增加有关。编号:ACTRN12623001281684。
{"title":"Effect of the prone position on mechanical power in elective surgical patients under general anesthesia: A prospective observational study.","authors":"Berrak S Aydın, Eren Açıkgöz","doi":"10.15537/smj.2024.45.8.20240242","DOIUrl":"10.15537/smj.2024.45.8.20240242","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate how the prone position influences mechanical power (MP) during elective surgical procedures.</p><p><strong>Methods: </strong>In this prospective study carried out at Karadeniz Ereğli Government Hospital, Zonguldak, Turkey, from January 2024 to February 2024, 76 patients under general anesthesia were evaluated at different time points during the surgical procedure. Hemodynamic, laboratory, and mechanical ventilation data were also recorded.</p><p><strong>Results: </strong>The MP increased in the prone position at the beginning of surgery. Transitioning to the supine position at the end of surgery led to a decrease in MP. At the end of surgery, the mean MP in supine and prone positions was found to be higher compared to those measured in the first hour of surgery. Mechanical power and body mass index (BMI) exhibited a significant positive correlation.</p><p><strong>Conclusion: </strong>Position changes influence MP. Returning to the prone position increases MP. An increase in BMI is associated with an increase in MP.<b>ANZCTR Reg. No.: ACTRN12623001281684</b>.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288489/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141793293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum levels of zinc, folate, and vitamin B12 in healthy children aged 3-12 months: Is routine screening necessary? 3-12 个月健康儿童血清中的锌、叶酸和维生素 B12 含量:是否有必要进行常规筛查?
IF 1.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-01 DOI: 10.15537/smj.2024.45.8.20240248
Furkan Kalayci, Metin Yigit

Objectives: To retrospectively assess the serum levels of zinc, folate, and vitamin B12 in healthy children aged between 3-12 months.

Methods: This study includes healthy children aged between 3-12 months who presented to the pediatric outpatient clinics of Ankara Bilkent City Hospital, Ankara, Turkey, between January 2020 and July 2022. The levels of serum zinc, folate, and vitamin B12 were evaluated retrospectively.

Results: Of the 495 patients enrolled in our study, 248 (50.1%) were female. The median age of the patients was 10 (range: 7-12) months. Zinc deficiency was detected in 24 (4.8%) patients, and vitamin B12 deficiency was found in 49 (9.8%) patients. No folate deficiency was observed in any patient. There was no significant correlation between the patients' height and weight percentiles and their serum levels of zinc, folate, and vitamin B12 (p>0.05 for each).

Conclusion: In conclusion, we do not recommend routine screening for zinc, folate, and vitamin B12 levels in children under 12 months of age without active issues or chronic diseases due to the associated costs. We propose that evaluating serum levels of zinc, folate, and vitamin B12 is a more appropriate clinical approach in children at risk for micronutrient deficiencies and in selected patient groups.

目的:回顾性评估 3-12 个月大健康儿童血清中的锌、叶酸和维生素 B12 水平:回顾性评估 3-12 个月大健康儿童血清中锌、叶酸和维生素 B12 的水平:本研究包括 2020 年 1 月至 2022 年 7 月期间在土耳其安卡拉比尔肯特市医院儿科门诊就诊的 3-12 个月大健康儿童。我们对这些儿童的血清锌、叶酸和维生素 B12 水平进行了回顾性评估:在 495 名参与研究的患者中,248 名(50.1%)为女性。患者的中位年龄为 10 个月(7-12 个月)。24名(4.8%)患者发现锌缺乏症,49名(9.8%)患者发现维生素B12缺乏症。没有发现任何患者缺乏叶酸。患者的身高和体重百分位数与其血清中的锌、叶酸和维生素 B12 水平之间没有明显的相关性(P>0.05):总之,我们不建议对 12 个月以下无活动性问题或慢性疾病的儿童进行锌、叶酸和维生素 B12 水平的常规筛查,原因是相关费用太高。我们建议,对于有微量营养素缺乏风险的儿童和特定患者群体,评估血清中锌、叶酸和维生素 B12 的水平是更合适的临床方法。
{"title":"Serum levels of zinc, folate, and vitamin B12 in healthy children aged 3-12 months: Is routine screening necessary?","authors":"Furkan Kalayci, Metin Yigit","doi":"10.15537/smj.2024.45.8.20240248","DOIUrl":"10.15537/smj.2024.45.8.20240248","url":null,"abstract":"<p><strong>Objectives: </strong>To retrospectively assess the serum levels of zinc, folate, and vitamin B12 in healthy children aged between 3-12 months.</p><p><strong>Methods: </strong>This study includes healthy children aged between 3-12 months who presented to the pediatric outpatient clinics of Ankara Bilkent City Hospital, Ankara, Turkey, between January 2020 and July 2022. The levels of serum zinc, folate, and vitamin B12 were evaluated retrospectively.</p><p><strong>Results: </strong>Of the 495 patients enrolled in our study, 248 (50.1%) were female. The median age of the patients was 10 (range: 7-12) months. Zinc deficiency was detected in 24 (4.8%) patients, and vitamin B12 deficiency was found in 49 (9.8%) patients. No folate deficiency was observed in any patient. There was no significant correlation between the patients' height and weight percentiles and their serum levels of zinc, folate, and vitamin B12 (<i>p</i>>0.05 for each).</p><p><strong>Conclusion: </strong>In conclusion, we do not recommend routine screening for zinc, folate, and vitamin B12 levels in children under 12 months of age without active issues or chronic diseases due to the associated costs. We propose that evaluating serum levels of zinc, folate, and vitamin B12 is a more appropriate clinical approach in children at risk for micronutrient deficiencies and in selected patient groups.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288490/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141793373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The protagonist of contemporary and emerging nanotechnology-based theranostics and therapeutic approaches in reshaping intensive care unit. 以纳米技术为基础的当代和新兴疗法和治疗方法是重塑重症监护室的主角。
IF 1.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-01 DOI: 10.15537/smj.2024.45.8.20240069
Ling Xie, Yun Chen

To maintain a clean and hygienic environment in the intensive care unit (ICU) is crucial for ensuring patient safety, preventing infections, and reducing healthcare-associated complications. With the increasing prevalence of infections and the emergence of viral and bacterial resistance to standard antiseptics, there is a pressing need for innovative antiseptic solutions. Nanotechnology is increasingly being employed in medicine, particularly focusing on mitigating the activities of various pathogens, including those associated with hospital-acquired infections. This paper explores the current impact of nanotechnology, with a particular focus on bacterial infections and SARS-CoV-2, which significantly strain healthcare systems, and then discusses how nanotechnology can enhance existing treatment methodologies. We highlight the effectiveness of the nanotechnology-based bactericide Bio-Kil in reducing bacterial counts in an ICU. The aim is to educate healthcare professionals on the existing role and prospects of nanotechnology in addressing prevalent infectious diseases.

保持重症监护室(ICU)环境的清洁卫生对于确保患者安全、预防感染和减少医疗相关并发症至关重要。随着感染率的上升以及病毒和细菌对标准防腐剂耐药性的出现,迫切需要创新的防腐解决方案。纳米技术正越来越多地应用于医学领域,特别是侧重于减轻各种病原体的活动,包括与医院感染有关的病原体。本文探讨了纳米技术目前产生的影响,尤其关注细菌感染和严重急性呼吸系统综合症(SARS-CoV-2)给医疗系统带来的巨大压力,然后讨论了纳米技术如何增强现有的治疗方法。我们重点介绍了基于纳米技术的杀菌剂 Bio-Kil 在减少重症监护室细菌数量方面的有效性。目的是让医疗保健专业人员了解纳米技术在应对流行传染病方面的现有作用和前景。
{"title":"The protagonist of contemporary and emerging nanotechnology-based theranostics and therapeutic approaches in reshaping intensive care unit.","authors":"Ling Xie, Yun Chen","doi":"10.15537/smj.2024.45.8.20240069","DOIUrl":"10.15537/smj.2024.45.8.20240069","url":null,"abstract":"<p><p>To maintain a clean and hygienic environment in the intensive care unit (ICU) is crucial for ensuring patient safety, preventing infections, and reducing healthcare-associated complications. With the increasing prevalence of infections and the emergence of viral and bacterial resistance to standard antiseptics, there is a pressing need for innovative antiseptic solutions. Nanotechnology is increasingly being employed in medicine, particularly focusing on mitigating the activities of various pathogens, including those associated with hospital-acquired infections. This paper explores the current impact of nanotechnology, with a particular focus on bacterial infections and SARS-CoV-2, which significantly strain healthcare systems, and then discusses how nanotechnology can enhance existing treatment methodologies. We highlight the effectiveness of the nanotechnology-based bactericide Bio-Kil in reducing bacterial counts in an ICU. The aim is to educate healthcare professionals on the existing role and prospects of nanotechnology in addressing prevalent infectious diseases.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288488/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141793376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Could Botox make walking easier in children with cerebral palsy? 肉毒杆菌素能让脑瘫儿童更容易行走吗?
IF 1.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-01
{"title":"Could Botox make walking easier in children with cerebral palsy?","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11376707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142111529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Saudi Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1